Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers
- Autores
- Ubillos, Lluis; Freire, Teresa; Berriel, Edgardo; Chiribao, María Laura; Chiale, Carolina; Festari, María Florencia; Medeiros, Andrea; Mazal, Daniel; Rondan, Mariella; Bollati Fogolin, Mariela; Rabinovich, Gabriel Adrián; Robello, Carlos; Osinaga, Eduardo
- Año de publicación
- 2016
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Trypanosoma cruzi, the protozoan parasite that causes Chagas' disease, has anticancer effects mediated, at least in part, by parasite-derived products which inhibit growth of tumor cells. We investigated whether immunity to T. cruzi antigens could induce antitumor activity, using two rat models which reproduce human carcinogenesis: colon cancer induced by 1,2-dimethylhydrazine (DMH), and mammary cancer induced by N-nitroso-N-methylurea (NMU). We found that vaccination with T. cruzi epimastigote lysates strongly inhibits tumor development in both animal models. Rats immunized with T. cruzi antigens induce activation of both CD4(+) and CD8(+) T cells and splenocytes from these animals showed higher cytotoxic responses against tumors as compared to rats receiving adjuvant alone. Tumor-associated immune responses included increasing number of CD11b/c(+) His48(-) MHC II(+) cells corresponding to macrophages and/or dendritic cells, which exhibited augmented NADPH-oxidase activity. We also found that T. cruzi lysate vaccination developed antibodies specific for colon and mammary rat cancer cells, which were capable of mediating antibody-dependent cellular cytotoxicity (ADCC) in vitro. Anti-T. cruzi antibodies cross-reacted with human colon and breast cancer cell lines and recognized 41/60 (68%) colon cancer and 38/63 (60%) breast cancer samples in a series of 123 human tumors. Our results suggest that T. cruzi antigens can evoke an integrated antitumor response involving both the cellular and humoral components of the immune response and provide novel insights into the understanding of the intricate relationship between parasite infection and tumor growth
Fil: Ubillos, Lluis. Universidad de la República; Uruguay
Fil: Freire, Teresa. Universidad de la República; Uruguay
Fil: Berriel, Edgardo. Instituto Pasteur de Montevideo; Uruguay. Universidad de la República; Uruguay
Fil: Chiribao, María Laura. Universidad de la República; Uruguay. Instituto Pasteur de Montevideo; Uruguay
Fil: Chiale, Carolina. Universidad de la República; Uruguay
Fil: Festari, María Florencia. Universidad de la República; Uruguay. Instituto Pasteur de Montevideo; Uruguay
Fil: Medeiros, Andrea. Universidad de la República; Uruguay. Instituto Pasteur de Montevideo; Uruguay
Fil: Mazal, Daniel. Universidad de la República; Uruguay
Fil: Rondan, Mariella. Universidad de la República; Uruguay
Fil: Bollati Fogolin, Mariela. Instituto Pasteur de Montevideo; Uruguay
Fil: Rabinovich, Gabriel Adrián. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Robello, Carlos. Universidad de la República; Uruguay. Instituto Pasteur de Montevideo; Uruguay
Fil: Osinaga, Eduardo. Universidad de la República; Uruguay. Instituto Pasteur de Montevideo; Uruguay - Materia
-
Trypanosoma Cruzi
Immunology
Cancer
Breast Neoplasm
Colonic Neoplasms - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/23363
Ver los metadatos del registro completo
| id |
CONICETDig_7f2b5ca00c3743e8d34b573e2026d53f |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/23363 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancersUbillos, LluisFreire, TeresaBerriel, EdgardoChiribao, María LauraChiale, CarolinaFestari, María FlorenciaMedeiros, AndreaMazal, DanielRondan, MariellaBollati Fogolin, MarielaRabinovich, Gabriel AdriánRobello, CarlosOsinaga, EduardoTrypanosoma CruziImmunologyCancerBreast NeoplasmColonic Neoplasmshttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Trypanosoma cruzi, the protozoan parasite that causes Chagas' disease, has anticancer effects mediated, at least in part, by parasite-derived products which inhibit growth of tumor cells. We investigated whether immunity to T. cruzi antigens could induce antitumor activity, using two rat models which reproduce human carcinogenesis: colon cancer induced by 1,2-dimethylhydrazine (DMH), and mammary cancer induced by N-nitroso-N-methylurea (NMU). We found that vaccination with T. cruzi epimastigote lysates strongly inhibits tumor development in both animal models. Rats immunized with T. cruzi antigens induce activation of both CD4(+) and CD8(+) T cells and splenocytes from these animals showed higher cytotoxic responses against tumors as compared to rats receiving adjuvant alone. Tumor-associated immune responses included increasing number of CD11b/c(+) His48(-) MHC II(+) cells corresponding to macrophages and/or dendritic cells, which exhibited augmented NADPH-oxidase activity. We also found that T. cruzi lysate vaccination developed antibodies specific for colon and mammary rat cancer cells, which were capable of mediating antibody-dependent cellular cytotoxicity (ADCC) in vitro. Anti-T. cruzi antibodies cross-reacted with human colon and breast cancer cell lines and recognized 41/60 (68%) colon cancer and 38/63 (60%) breast cancer samples in a series of 123 human tumors. Our results suggest that T. cruzi antigens can evoke an integrated antitumor response involving both the cellular and humoral components of the immune response and provide novel insights into the understanding of the intricate relationship between parasite infection and tumor growthFil: Ubillos, Lluis. Universidad de la República; UruguayFil: Freire, Teresa. Universidad de la República; UruguayFil: Berriel, Edgardo. Instituto Pasteur de Montevideo; Uruguay. Universidad de la República; UruguayFil: Chiribao, María Laura. Universidad de la República; Uruguay. Instituto Pasteur de Montevideo; UruguayFil: Chiale, Carolina. Universidad de la República; UruguayFil: Festari, María Florencia. Universidad de la República; Uruguay. Instituto Pasteur de Montevideo; UruguayFil: Medeiros, Andrea. Universidad de la República; Uruguay. Instituto Pasteur de Montevideo; UruguayFil: Mazal, Daniel. Universidad de la República; UruguayFil: Rondan, Mariella. Universidad de la República; UruguayFil: Bollati Fogolin, Mariela. Instituto Pasteur de Montevideo; UruguayFil: Rabinovich, Gabriel Adrián. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Robello, Carlos. Universidad de la República; Uruguay. Instituto Pasteur de Montevideo; UruguayFil: Osinaga, Eduardo. Universidad de la República; Uruguay. Instituto Pasteur de Montevideo; UruguayJohn Wiley & Sons Inc2016-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfhttp://hdl.handle.net/11336/23363Ubillos, Lluis; Freire, Teresa; Berriel, Edgardo; Chiribao, María Laura; Chiale, Carolina; et al.; Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers; John Wiley & Sons Inc; International Journal Of Cancer. Journal International Du Cancer.; 138; 7; 1-4-2016; 1719-17310020-71361097-0215CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://onlinelibrary.wiley.com/doi/10.1002/ijc.29910/abstractinfo:eu-repo/semantics/altIdentifier/doi/10.1002/ijc.29910info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-22T11:39:34Zoai:ri.conicet.gov.ar:11336/23363instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-22 11:39:35.06CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers |
| title |
Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers |
| spellingShingle |
Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers Ubillos, Lluis Trypanosoma Cruzi Immunology Cancer Breast Neoplasm Colonic Neoplasms |
| title_short |
Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers |
| title_full |
Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers |
| title_fullStr |
Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers |
| title_full_unstemmed |
Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers |
| title_sort |
Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers |
| dc.creator.none.fl_str_mv |
Ubillos, Lluis Freire, Teresa Berriel, Edgardo Chiribao, María Laura Chiale, Carolina Festari, María Florencia Medeiros, Andrea Mazal, Daniel Rondan, Mariella Bollati Fogolin, Mariela Rabinovich, Gabriel Adrián Robello, Carlos Osinaga, Eduardo |
| author |
Ubillos, Lluis |
| author_facet |
Ubillos, Lluis Freire, Teresa Berriel, Edgardo Chiribao, María Laura Chiale, Carolina Festari, María Florencia Medeiros, Andrea Mazal, Daniel Rondan, Mariella Bollati Fogolin, Mariela Rabinovich, Gabriel Adrián Robello, Carlos Osinaga, Eduardo |
| author_role |
author |
| author2 |
Freire, Teresa Berriel, Edgardo Chiribao, María Laura Chiale, Carolina Festari, María Florencia Medeiros, Andrea Mazal, Daniel Rondan, Mariella Bollati Fogolin, Mariela Rabinovich, Gabriel Adrián Robello, Carlos Osinaga, Eduardo |
| author2_role |
author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Trypanosoma Cruzi Immunology Cancer Breast Neoplasm Colonic Neoplasms |
| topic |
Trypanosoma Cruzi Immunology Cancer Breast Neoplasm Colonic Neoplasms |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
| dc.description.none.fl_txt_mv |
Trypanosoma cruzi, the protozoan parasite that causes Chagas' disease, has anticancer effects mediated, at least in part, by parasite-derived products which inhibit growth of tumor cells. We investigated whether immunity to T. cruzi antigens could induce antitumor activity, using two rat models which reproduce human carcinogenesis: colon cancer induced by 1,2-dimethylhydrazine (DMH), and mammary cancer induced by N-nitroso-N-methylurea (NMU). We found that vaccination with T. cruzi epimastigote lysates strongly inhibits tumor development in both animal models. Rats immunized with T. cruzi antigens induce activation of both CD4(+) and CD8(+) T cells and splenocytes from these animals showed higher cytotoxic responses against tumors as compared to rats receiving adjuvant alone. Tumor-associated immune responses included increasing number of CD11b/c(+) His48(-) MHC II(+) cells corresponding to macrophages and/or dendritic cells, which exhibited augmented NADPH-oxidase activity. We also found that T. cruzi lysate vaccination developed antibodies specific for colon and mammary rat cancer cells, which were capable of mediating antibody-dependent cellular cytotoxicity (ADCC) in vitro. Anti-T. cruzi antibodies cross-reacted with human colon and breast cancer cell lines and recognized 41/60 (68%) colon cancer and 38/63 (60%) breast cancer samples in a series of 123 human tumors. Our results suggest that T. cruzi antigens can evoke an integrated antitumor response involving both the cellular and humoral components of the immune response and provide novel insights into the understanding of the intricate relationship between parasite infection and tumor growth Fil: Ubillos, Lluis. Universidad de la República; Uruguay Fil: Freire, Teresa. Universidad de la República; Uruguay Fil: Berriel, Edgardo. Instituto Pasteur de Montevideo; Uruguay. Universidad de la República; Uruguay Fil: Chiribao, María Laura. Universidad de la República; Uruguay. Instituto Pasteur de Montevideo; Uruguay Fil: Chiale, Carolina. Universidad de la República; Uruguay Fil: Festari, María Florencia. Universidad de la República; Uruguay. Instituto Pasteur de Montevideo; Uruguay Fil: Medeiros, Andrea. Universidad de la República; Uruguay. Instituto Pasteur de Montevideo; Uruguay Fil: Mazal, Daniel. Universidad de la República; Uruguay Fil: Rondan, Mariella. Universidad de la República; Uruguay Fil: Bollati Fogolin, Mariela. Instituto Pasteur de Montevideo; Uruguay Fil: Rabinovich, Gabriel Adrián. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina Fil: Robello, Carlos. Universidad de la República; Uruguay. Instituto Pasteur de Montevideo; Uruguay Fil: Osinaga, Eduardo. Universidad de la República; Uruguay. Instituto Pasteur de Montevideo; Uruguay |
| description |
Trypanosoma cruzi, the protozoan parasite that causes Chagas' disease, has anticancer effects mediated, at least in part, by parasite-derived products which inhibit growth of tumor cells. We investigated whether immunity to T. cruzi antigens could induce antitumor activity, using two rat models which reproduce human carcinogenesis: colon cancer induced by 1,2-dimethylhydrazine (DMH), and mammary cancer induced by N-nitroso-N-methylurea (NMU). We found that vaccination with T. cruzi epimastigote lysates strongly inhibits tumor development in both animal models. Rats immunized with T. cruzi antigens induce activation of both CD4(+) and CD8(+) T cells and splenocytes from these animals showed higher cytotoxic responses against tumors as compared to rats receiving adjuvant alone. Tumor-associated immune responses included increasing number of CD11b/c(+) His48(-) MHC II(+) cells corresponding to macrophages and/or dendritic cells, which exhibited augmented NADPH-oxidase activity. We also found that T. cruzi lysate vaccination developed antibodies specific for colon and mammary rat cancer cells, which were capable of mediating antibody-dependent cellular cytotoxicity (ADCC) in vitro. Anti-T. cruzi antibodies cross-reacted with human colon and breast cancer cell lines and recognized 41/60 (68%) colon cancer and 38/63 (60%) breast cancer samples in a series of 123 human tumors. Our results suggest that T. cruzi antigens can evoke an integrated antitumor response involving both the cellular and humoral components of the immune response and provide novel insights into the understanding of the intricate relationship between parasite infection and tumor growth |
| publishDate |
2016 |
| dc.date.none.fl_str_mv |
2016-04-01 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/23363 Ubillos, Lluis; Freire, Teresa; Berriel, Edgardo; Chiribao, María Laura; Chiale, Carolina; et al.; Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers; John Wiley & Sons Inc; International Journal Of Cancer. Journal International Du Cancer.; 138; 7; 1-4-2016; 1719-1731 0020-7136 1097-0215 CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/23363 |
| identifier_str_mv |
Ubillos, Lluis; Freire, Teresa; Berriel, Edgardo; Chiribao, María Laura; Chiale, Carolina; et al.; Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers; John Wiley & Sons Inc; International Journal Of Cancer. Journal International Du Cancer.; 138; 7; 1-4-2016; 1719-1731 0020-7136 1097-0215 CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://onlinelibrary.wiley.com/doi/10.1002/ijc.29910/abstract info:eu-repo/semantics/altIdentifier/doi/10.1002/ijc.29910 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/vnd.openxmlformats-officedocument.wordprocessingml.document application/pdf |
| dc.publisher.none.fl_str_mv |
John Wiley & Sons Inc |
| publisher.none.fl_str_mv |
John Wiley & Sons Inc |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1846782061261619200 |
| score |
12.982451 |